Waking at 3 a.m. drenched in sweat, losing the word you were about to say mid-meeting, or sensing that your body has changed the rules can happen during the menopause transition. Hormonal changes may contribute, but symptoms such as poor sleep and trouble concentrating can have other causes, too.
Menopause is a normal life stage, but symptoms can start early, last for years, and affect sleep, mood, work, relationships, and comfort. Treatments exist, including hormone therapy, and understanding them is the first step toward deciding what fits your situation.
Perimenopause: The Years Before Menopause
For women who are still having natural menstrual cycles, menopause is generally recognized after 12 consecutive months without a period. The years leading up to it, called perimenopause, often begin in the 40s (sometimes earlier) and can last several years.
During this time, estrogen and progesterone levels don’t decline in a neat, predictable line. They fluctuate, sometimes wildly, which is why perimenopause can feel so confusing. Common symptoms include:
- Hot flashes and night sweats. Sudden waves of heat can strike in the middle of a meeting or the middle of the night.
- Mood changes. Irritability, anxiety, and low mood are common, and some women notice shifts that feel out of character.
- Sleep disruption. Night sweats are part of the story, but hormonal shifts can affect sleep on their own.
- Brain fog. Trouble concentrating or finding the right word is common.
- Irregular periods. Cycles may get shorter, longer, heavier, lighter, or skip altogether.
These symptoms compound. When you’re sleeping poorly, feeling anxious, and dealing with hot flashes at once, everything gets harder. Recognizing the pattern early means you can get support sooner. (Very heavy bleeding, bleeding between periods, or any bleeding after menopause should always be evaluated by a provider.)
Vaginal and Urinary Symptoms (GSM)
One group of symptoms deserves its own conversation because it’s so often overlooked. Genitourinary syndrome of menopause (GSM) is the medical term for the changes that occur in the vagina, vulva, and urinary tract as estrogen levels fall. It can include:
- Vaginal dryness, burning, or irritation
- Pain with intercourse
- Urinary urgency, frequency, or discomfort with urination
- Recurrent urinary tract infections
Unlike hot flashes, which often fade over time, GSM tends to persist and can worsen without treatment. Many women never mention these symptoms, and effective treatment exists.
Sexual desire is a separate issue. Low libido during the menopause transition can have many contributors, including poor sleep, mood changes, pain with sex, relationship factors, stress, and medications. It needs its own evaluation rather than being lumped in with vaginal symptoms.
What Hormone Therapy Actually Does
Menopausal hormone therapy (MHT or HRT) replaces some of the hormones your body is making less of. For women with moderate to severe symptoms, systemic estrogen (estrogen that circulates throughout the body) is the most effective treatment available for hot flashes and night sweats. It can also:
- Improve sleep when night sweats are the cause
- Ease vaginal and urinary symptoms
- Help prevent bone loss
- Support mood and quality of life for some women, particularly when symptoms are driven by hormonal changes
Hormone therapy isn’t a treatment for everything. It’s not a weight-loss drug, and it isn’t a substitute for treating depression or anxiety when those conditions need their own care.
Why Progesterone Is Sometimes Part of the Plan
If you have a uterus, estrogen taken systemically needs a partner. Estrogen alone can cause the uterine lining to thicken, which raises the risk of endometrial hyperplasia and endometrial cancer. Adding a progestogen (progesterone or a progestin-type medication) protects the lining. That protection is the main reason it’s included.
Women who’ve had a hysterectomy generally don’t need a progestogen. Low-dose vaginal estrogen, used for local symptoms, typically doesn’t require one either.
A Note on Testosterone
You may hear testosterone mentioned as part of menopause care. It is not a routine component of menopausal hormone therapy. In the U.S., there is no FDA-approved testosterone product for women, and evidence supports its use mainly for a specific diagnosis: distressing low sexual desire (hypoactive sexual desire disorder, or HSDD) in postmenopausal women, after other contributing factors have been addressed. Evidence does not support routinely prescribing it for hot flashes, mood, energy, or weight loss. If you’re curious about it, it’s a focused conversation to have with a provider experienced in menopause care.
Is Hormone Therapy Safe? It Depends on Which One
Years of conflicting headlines have left many women unsure about hormone therapy. Part of the confusion is that “HRT” isn’t one medication with one risk profile. Risk and benefit depend on several things:
- Timing. For many healthy women who start within 10 years of menopause or before age 60, benefits often outweigh risks. Starting later calls for more individualized weighing of risk.
- Route. Oral estrogen passes through the liver and is associated with a higher risk of blood clots than transdermal estrogen (patch, gel, or spray). For many women, transdermal is an appealing option, particularly when clot risk is a concern.
- Systemic versus vaginal. Low-dose vaginal estrogen acts mostly locally, with very little absorption into the bloodstream, so its risk profile differs from systemic therapy.
- Estrogen alone versus estrogen plus a progestogen. The addition of a progestogen, and the type used, can influence breast cancer risk, and the two are studied separately for that reason.
- Formulation and dose. Different products and doses carry different risks.
- Your personal and family history. Breast cancer, blood clots, stroke, heart disease, liver disease, migraine with aura, and unexplained vaginal bleeding all matter.
Some women aren’t good candidates for systemic hormone therapy, and non-hormonal prescription options exist for hot flashes. A provider who reviews your full history can help you weigh the real tradeoffs for you, not for an average woman in a study.
"Bioidentical" Doesn't Mean What You Might Think
“Bioidentical” is one of the most misunderstood words in menopause care. It simply means a hormone is chemically identical to one your body makes, such as estradiol or progesterone. Three things are worth untangling:
- Bioidentical does not mean compounded. Many FDA-approved hormone products are bioidentical, including estradiol patches, gels, sprays, and tablets, vaginal estradiol creams, tablets, inserts, and rings, and oral micronized progesterone. These products have been tested for safety, effectiveness, dose consistency, and quality.
- Bioidentical does not mean pellets. Pellets are one delivery method, not a category of “natural” hormones. The FDA-approved options above are just as bioidentical.
- Compounded is not the same as FDA-approved. Custom-compounded hormone preparations, including pellets, aren’t FDA-approved and haven’t gone through the same review for safety, dosing accuracy, or consistency. Major medical societies generally recommend approved products over compounded ones when an approved option fits. With pellets in particular, the dose can’t easily be adjusted or stopped once placed, and hormone levels can be hard to predict. Some women are happy with them, but it’s a decision best made with full information.
If a provider recommends a particular product, it’s reasonable to ask: Is it FDA-approved? Is it bioidentical? What are the alternatives? These are fair questions for any provider, PrecisionMD included.
Vaginal Estrogen: An Underused Option
Low-dose vaginal estrogen comes as creams, tablets, inserts, and a ring. It treats GSM symptoms such as dryness and discomfort with sex and can help prevent recurrent UTIs. It does not treat an active urinary infection. Because absorption into the rest of the body is minimal at standard low doses, many women who aren’t candidates for systemic therapy can still use it. Women with a history of breast cancer are generally advised to start with non-hormonal options, and any decision about vaginal estrogen should be made together with their oncology team.
Since GSM is ongoing, treatment is often long-term, and stopping usually means symptoms return. Non-hormonal moisturizers and lubricants can help as well, but they don’t treat the underlying estrogen-deficient tissue changes the way vaginal estrogen does.
What About the "Menopause Belly"?
Many women notice weight settling around the midsection during this stage. Falling estrogen changes where the body stores fat, and muscle mass declines with age. Hormone therapy isn’t a weight-loss treatment, but if midsection changes are a concern, it’s worth raising alongside your other symptoms so a provider can look at the whole picture.
Beyond Menopause: Thinking Long-Term
Hormonal changes continue to affect your bones, heart, and overall health after menopause, so regular checkups, bone density screening, and cardiovascular risk assessment matter.
If you start hormone therapy, it needs periodic review, and there’s no automatic expiration date. How long to continue is an individual decision. A good plan includes regular reassessment of your symptoms, dose, delivery method, health history, and goals. Some women taper off after a few years, while others continue longer because the benefits still outweigh the risks for them.
Getting a Personalized Plan
Good menopause care starts with your symptoms, your health history, and your goals. At PrecisionMD, a provider will review all three, walk through your options (hormonal and non-hormonal), and revisit the plan as your needs change. Hormone therapy may or may not be part of it.
PrecisionMD has offices in Decatur and Madison and serves patients in Huntsville and across North Alabama.
👉 Contact PrecisionMD to schedule a menopause consultation.
This article is for educational purposes only and isn’t a substitute for personalized medical advice. Talk with your healthcare provider about what’s right for you.
Traci McCormick, MD
Author
